Prioritize Testing Over Medication Hesitation

There is a significant under-testing issue for primary aldosteroneism among patients with hypertension, with only about 2.1% of those with resistant hypertension and 2.7% with hypertension and hypokalemia screened. This lack of testing can be attributed to clinicians' uncertainties regarding medication management. The recommendation is to prioritize testing over concerns about medications; clinicians should test first and not halt drug treatments, as this may lead to false positives. A specific testing cutoff for aldosterone is suggested to enhance diagnostic accuracy.